Fox Run Management L.l.c. adds PerkinElmer (PKI) to its portfolio

PerkinElmer (PKI) : Fox Run Management L.l.c. added new position in PerkinElmer during the most recent quarter end. The investment management firm now holds 11,600 shares of PerkinElmer which is valued at $624,312 , the company said in a statement filed on Oct 12, 2016 with the SEC.PerkinElmer makes up approximately 0.38% of Fox Run Management L.l.c.’s portfolio.

Other Hedge Funds, Including , First National Bank Of Omaha reduced its stake in PKI by selling 1,305 shares or 1.12% in the most recent quarter. The Hedge Fund company now holds 114,877 shares of PKI which is valued at $6,182,680. PerkinElmer makes up approx 0.49% of First National Bank Of Omaha’s portfolio. First Mercantile Trust Co sold out all of its stake in PKI during the most recent quarter. The investment firm sold 14,975 shares of PKI which is valued $834,108.Exxonmobil Investment Management Inc Tx reduced its stake in PKI by selling 288 shares or 1.02% in the most recent quarter. The Hedge Fund company now holds 27,934 shares of PKI which is valued at $1,555,924. PerkinElmer makes up approx 0.03% of Exxonmobil Investment Management Inc Tx’s portfolio.

PerkinElmer closed down -1.64 points or -2.96% at $53.82 with 8,31,179 shares getting traded on Tuesday. Post opening the session at $54.83, the shares hit an intraday low of $53.44 and an intraday high of $54.83 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, PerkinElmer reported $0.67 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.66. The company had revenue of $573.00 million for the quarter, compared to analysts expectations of $575.66 million. The company’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.60 EPS.

Many Wall Street Analysts have commented on PerkinElmer. Mizuho Downgraded PerkinElmer on Aug 5, 2016 to ” Neutral”, Price Target of the shares are set at $56.

PerkinElmer Inc. is a provider of products services and solutions to the diagnostics research environmental industrial and laboratory services markets. The Company operates its business in two segments: Human Health and Environmental Health. The Company’s Human Health segment concentrates on developing diagnostics tools and applications to help detect diseases earlier and more accurately and to accelerate the discovery and development of new therapies. The Company’s Environmental Health segment provides products services and solutions to facilitate the creation of safer food and consumer products more secure surroundings and efficient energy resources. The Company markets its products and services in more than 150 countries.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

PerkinElmer - Is it time to Sell?

Top Brokerage Firms are advising their investors on PerkinElmer. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.